Anteris Technologies Global (AVR) Liabilities and Shareholders Equity (2024 - 2026)
Anteris Technologies Global (AVR) posted quarterly Liabilities and Shareholders Equity of $294.7 million for Q1 2026, up 401.3% year-over-year from $58.8 million in Q1 2025, and up 1181.57% quarter-over-quarter from $23.0 million in Q4 2025.
Anteris Technologies Global (AVR) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $294.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 401.3% year-over-year to $294.7 million; the TTM figure through Mar 2026 stood at $376.7 million (up 170.03% YoY), while the FY2025 annual figure was $23.0 million, down 71.5% from the prior year.
- Liabilities and Shareholders Equity advanced to $294.7 million in Q1 2026 per AVR's latest filing, from $23.0 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $294.7 million in Q1 2026 and bottomed at $19.1 million in Q3 2025.
- Historically, Liabilities and Shareholders Equity has averaged $86.0 million across 3 years, with a median of $49.3 million in 2025.
- Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity sank 71.5% — and 2026, when it surged 401.3%.
- Anteris Technologies Global's Liabilities and Shareholders Equity stood at $80.7 million in 2024, then tumbled by 71.5% to $23.0 million in 2025, then jumped by 1181.57% to $294.7 million in 2026.
- Business Quant data shows AVR's Liabilities and Shareholders Equity at $294.7 million in Q1 2026, $23.0 million in Q4 2025, and $19.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Anteris Technologies Global | 875.09 Mn | 875.09 Mn | 776,000.00 | 272.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 272.51 Mn |
| Mar 31, 2026 | 294.72 Mn |
| Dec 31, 2025 | 23.00 Mn |
| Sep 30, 2025 | 19.07 Mn |
| Jun 30, 2025 | 39.88 Mn |
| Mar 31, 2025 | 58.79 Mn |
| Dec 31, 2024 | 80.70 Mn |